Research Article

Distribution of Peripheral Lymphocyte Populations in Primary Sjögren’s Syndrome Patients

Table 4

Distribution of CD8+ lymphocyte subpopulations in peripheral blood of pSS patients and controls.

Patients1I-controls2II-pSS Abs3III-pSS Abs+
I-III-IIIII-III

CD8+ lymphocyte population
 CD8highCD57+CD27+
  %45.306 ± 3.8995.329 ± 5.4318.239 ± 8.239NSNS0.032
  A. count#34.26 ± 29.1127.05 ± 33.5742.59 ± 33.12NSNS0.011
 CD8highCD57+CD27
  %422.67 ± 13.3325.52 ± 17.4227.40 ± 19.55NSNSNS
  A. count#150.6 ± 119.7143.4 ± 157.7155.2 ± 136.8NSNSNS
 CD8highCD57CD27+
  %459.13 ± 17.5446.51 ± 22.0047.16 ± 22.290.026NSNS
  A. count#387.3 ± 211.4227.9 ± 186.6224.8 ± 129.30.00030.005NS
 CD8highCD57CD27
  %413.10 ± 8.11222.60 ± 15.3717.18 ± 11.200.024NSNS
  A. count#85.79 ± 73.99119.1 ± 126.799.46 ± 85.96NSNSNS
 CD8+FoxP3
  %510.59 ± 15.165.881 ± 6.6736.498 ± 7.939NSNSNS
  A. count#91.42 ± 126.151.19 ± 86.7250.49 ± 60.37NSNSNS

I group: healthy controls; 2II group: pSS patients without anti-SSA/SSB; 3III group: pSS patients with anti-SSA and/or anti-SSB; %4: proportion of all CD8high lymphocytes; %5: proportion of all CD8+ lymphocytes. A. count#: absolute count of cells in 1 μL of blood. *Mann-Whitney test. NS: not significant.